Lincoln National Corp Bio Rad Laboratories, Inc. Transaction History

Lincoln National Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$350.25 - $422.63 $1,751 - $2,113	-5 Reduced 0.72%	694 $248,000
Q2 2023 Aug 04, 2023	SELL	$359.49 - $486.4 $10,784 - $14,592	-30 Reduced 4.12%	699 $265,000
Q1 2023 May 01, 2023	BUY	$418.69 - $503.0 $15,910 - $19,114	38 Added 5.5%	729 $349,000
Q4 2022 Feb 07, 2023	BUY	$351.71 - $456.01 $243,031 - $315,102	691 New	691 $290,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.